Literature DB >> 28505975

Reduced Cardiovascular Functions in Patients with Alzheimer's Disease.

Wang-Sheng Jin, Xian-Le Bu, Ye-Ran Wang, Ling Li, Wei-Wei Li, Yu-Hui Liu, Chi Zhu, Xiu-Qing Yao, Yang Chen, Chang-Yue Gao, Tao Zhang, Hua-Dong Zhou, Fan Zeng, Yan-Jiang Wang.   

Abstract

Previous studies have suggested that cardiovascular functions might play a critical role in Alzheimer's disease (AD) pathogenesis. However, the relationship among heart function, blood flow of cerebral vessels, and AD remains unclear. In the present study, AD patients (n = 34) and age- and gender-matched cognitively normal controls (n = 34) were recruited. Demographic and comorbidity information was collected. The ejection fraction was measured using echocardiography, and the mean velocity, pulsatility index (PI), and resistance index (RI) of the basilar artery (BA), left terminal internal carotid artery (LTICA), and right terminal internal carotid artery (RTICA) were measured using transcranial Doppler. The data of lacunae, white matter changes, and plaques in the aortic arch and carotid arteries were collected from brain magnetic resonance imaging and computed tomography angiography images. Compared with normal controls, AD patients had lower ejection fractions and cerebral blood flow velocities and higher RI and PI in the BA, LTICA, and RTICA, as well as more plaques in the aortic and carotid arteries. In the multivariate logistic regression analysis, the ejection fraction and the mean velocity of the BA and LTICA were independently associated with AD after adjusting for age, gender, education, vascular risk factors, arterial plaques, and brain ischemic lesions detected in the brain images. These findings suggest that heart function and vascular condition may play important roles in AD pathogenesis. Improving cardiovascular functions could be a promising approach for the prevention and treatment of AD.

Entities:  

Keywords:  Alzheimer’s disease; cerebral blood flow; ejection fractions; heart

Mesh:

Year:  2017        PMID: 28505975     DOI: 10.3233/JAD-170088

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Amyloidosis of the Brain and Heart: Two Sides of the Same Coin?

Authors:  Chris L Schaich; Mathew S Maurer; Neelesh K Nadkarni
Journal:  JACC Heart Fail       Date:  2019-02       Impact factor: 12.035

2.  Angiotensin (1-7) Expressing Probiotic as a Potential Treatment for Dementia.

Authors:  Abbi R Hernandez; Anisha Banerjee; Christy S Carter; Thomas W Buford
Journal:  Front Aging       Date:  2021-03-30

3.  Ferulic Acid Ameliorates Alzheimer's Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice.

Authors:  Ni-Ya Wang; Jin-Nan Li; Wei-Lin Liu; Qi Huang; Wen-Xing Li; Ya-Hong Tan; Fang Liu; Zi-Hua Song; Meng-Yue Wang; Ning Xie; Rong-Rong Mao; Ping Gan; Yu-Qiang Ding; Zhi Zhang; Bao-Ci Shan; Li-Dian Chen; Qi-Xin Zhou; Lin Xu
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

4.  Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells.

Authors:  Sehwan Jang; Xavier R Chapa-Dubocq; Rebecca M Parodi-Rullán; Silvia Fossati; Sabzali Javadov
Journal:  Cells       Date:  2022-01-22       Impact factor: 6.600

5.  Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer's Disease.

Authors:  Tasha R Womack; Craig T Vollert; Odochi Ohia-Nwoko; Monika Schmitt; Saghi Montazari; Tina L Beckett; David Mayerich; Michael Paul Murphy; Jason L Eriksen
Journal:  Front Cell Neurosci       Date:  2022-02-07       Impact factor: 5.505

Review 6.  Do Neurotrophins Connect Neurological Disorders and Heart Diseases?

Authors:  Masashi Fujitani; Yoshinori Otani; Hisao Miyajima
Journal:  Biomolecules       Date:  2021-11-19

7.  Decreased Vascular Pulsatility in Alzheimer's Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography.

Authors:  Holger Poppert; Timo Grimmer; Marion Ortner; Christine Hauser; Christoph Schmaderer; Claudia Muggenthaler; Alexander Hapfelmeier; Christian Sorg; Janine Diehl-Schmid; Alexander Kurz; Hans Förstl; Benno Ikenberg; Konstantin Kotliar
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-20       Impact factor: 2.570

Review 8.  Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives.

Authors:  Bin-Lu Sun; Yang Chen; Dong-Yu Fan; Chi Zhu; Fan Zeng; Yan-Jiang Wang
Journal:  Sci China Life Sci       Date:  2020-10-23       Impact factor: 6.038

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.